
1. General Information
Wegovy FlexTouch 0.5 mg is a pre-filled injectable pen containing semaglutide 0.5 mg per dose. Semaglutide mimics the action of the naturally occurring GLP-1 hormone, which is involved in appetite regulation and food intake.
Wegovy is prescribed for eligible people for long-term weight management, alongside dietary changes and physical activity. In certain adults with established cardiovascular disease and overweight or obesity, Wegovy may also be prescribed to reduce the risk of major cardiovascular events.
Exporter information: Phoenix Exim, Nagpur, India, supplies pharmaceutical products for international markets including the USA, UK, Australia, Singapore, Canada, South Korea and UAE, subject to applicable regulatory and import requirements.
2. Product Information
- Brand: Wegovy FlexTouch
- Active ingredient: Semaglutide
- Strength: 0.5 mg per dose
- Dosage form: Solution for subcutaneous injection
- Device: Pre-filled FlexTouch pen
- Doses: One pen generally provides four 0.5 mg doses
- Drug class: GLP-1 receptor agonist
- Prescription status: Prescription medicine
- Manufacturer: Novo Nordisk
- Route: Subcutaneous injection
The 0.5 mg FlexTouch formulation contains semaglutide at approximately 1.34 mg/mL, with each dose delivering 0.5 mg.
3. Uses of Wegovy FlexTouch 0.5 mg
Wegovy may be prescribed as an adjunct to a reduced-calorie diet and increased physical activity for:
- Weight loss in eligible adults with obesity.
- Weight management in eligible adults who are overweight and have a weight-related medical condition.
- Long-term maintenance of weight reduction.
- Weight management in eligible adolescents aged 12 years and above, according to applicable prescribing guidelines.
- Reduction of certain major cardiovascular risks in eligible adults with established cardiovascular disease and overweight or obesity.
4. Benefits of This Medicine
When prescribed appropriately, Wegovy may help:
- Reduce appetite and food intake.
- Support clinically meaningful weight reduction.
- Help maintain weight loss when continued as prescribed.
- Support long-term weight-management goals together with diet and physical activity.
- Reduce the risk of certain major cardiovascular events in eligible adults with established cardiovascular disease and overweight or obesity.
Results vary between individuals, and Wegovy should not be considered a replacement for a balanced diet or regular physical activity.
5. Side Effects of Wegovy FlexTouch 0.5 mg
Like other prescription medicines, Wegovy can cause side effects. Gastrointestinal effects are particularly common, especially while the dose is being increased.
Possible adverse effects include:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal pain
- Headache
- Tiredness
- Indigestion
- Bloating
- Burping
More serious reactions can include pancreatitis, gallbladder problems, dehydration-related kidney problems and severe gastrointestinal reactions. Hypoglycemia can occur particularly when Wegovy is used with insulin or certain insulin-secretagogue medicines.
6. Common Side Effects
Commonly reported effects include:
- Nausea
- Diarrhea
- Constipation
- Vomiting
- Abdominal discomfort or pain
- Headache
- Fatigue
- Bloating
- Indigestion
These effects may be more noticeable during dose escalation and can improve as the body becomes accustomed to treatment.
Seek urgent medical attention for severe or persistent abdominal pain, symptoms of a serious allergic reaction, significant dehydration, or other severe or unusual symptoms.
7. How to Use Wegovy FlexTouch 0.5 mg
Wegovy FlexTouch is administered once weekly by subcutaneous injection. It should be injected into the abdomen, thigh or upper arm. The injection site can be changed from one dose to another. It should not be injected into a vein or muscle.
The 0.5 mg strength is part of the dose-escalation regimen for many patients. The exact schedule and whether a patient should remain at or move beyond 0.5 mg must be determined by the prescribing healthcare professional.
Important: Follow the specific instructions supplied with the pen and your healthcare professional's directions. Do not change the dose, frequency or treatment duration on your own.
8. How Wegovy Works
Semaglutide acts similarly to GLP-1, a hormone involved in regulating appetite and food intake. By activating GLP-1 receptors, it can increase feelings of fullness and reduce appetite, helping decrease calorie intake.
Semaglutide also slows gastric emptying, particularly after administration, contributing to its effects on appetite and satiety.
Because Wegovy has a long duration of action, it is administered once weekly.
9. Safety Advice for This Medicine
- Use Wegovy only under the supervision of a qualified healthcare professional.
- Do not use it if you have had a serious allergic reaction to semaglutide or its ingredients.
- Wegovy is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- Tell your doctor about all medicines you take, particularly insulin or medicines that stimulate insulin release.
- Inform your healthcare professional if you have a history of pancreatitis, gallbladder disease, kidney problems or significant gastrointestinal disease.
- Maintain adequate fluid intake, particularly if vomiting or diarrhea occurs.
- Do not combine Wegovy with another semaglutide-containing product or another GLP-1 receptor agonist unless specifically directed by a healthcare professional.
- Do not share a FlexTouch pen between patients.
- Follow the storage conditions printed on the product packaging.
- Discuss Wegovy with your doctor if you are pregnant, planning pregnancy or breastfeeding.
10. Frequently Asked Questions (FAQs)
Q1. What is Wegovy FlexTouch 0.5 mg?
Wegovy FlexTouch 0.5 mg is a prescription injectable medicine containing semaglutide, used as part of a weight-management program.
Q2. How often is Wegovy 0.5 mg injected?
It is generally administered once weekly, according to the prescribed treatment schedule.
Q3. Is Wegovy 0.5 mg used for weight loss?
Yes. It can be prescribed for weight management in eligible patients alongside a reduced-calorie diet and increased physical activity.
Q4. Can I increase the dose myself?
No. Dose changes should be made only according to the prescribing healthcare professional's instructions.
Q5. Where is Wegovy injected?
It is injected subcutaneously into the abdomen, thigh or upper arm.
Q6. What is the most common side effect?
Nausea and other gastrointestinal symptoms are among the commonly reported adverse effects.
Q7. Can Wegovy be used with other GLP-1 medicines?
It should not be combined with another semaglutide-containing product or another GLP-1 receptor agonist unless specifically instructed by a healthcare professional.
Q8. Is Wegovy available as a prescription medicine?
Yes. Wegovy is classified as a prescription medicine in multiple markets.
11. Substitute for Wegovy FlexTouch 0.5 mg
There is no universally appropriate substitute for Wegovy. A healthcare professional may consider another semaglutide product or another GLP-1 receptor agonist depending on the patient's indication, medical history, dosage requirements and local regulatory approvals.
Examples of medicines containing related or different GLP-1-based therapies include Ozempic (semaglutide) and liraglutide-containing medicines, but they are not automatically interchangeable with Wegovy 0.5 mg. Product indications, strengths, dosing schedules and approved uses can differ.
Patients should consult a doctor or pharmacist before changing treatment.
12. Keywords
- Wegovy FlexTouch 0.5 mg Injection
- Wegovy 0.5 mg semaglutide injection
- Semaglutide 0.5 mg pre-filled pen
- Wegovy FlexTouch exporter from India
- Wegovy 0.5 mg pharmaceutical exporter
- Wegovy supplier from India
- Semaglutide injection exporter India
- Wegovy medicine exporter Nagpur
- Wegovy FlexTouch 0.5 mg supplier
- Wegovy 0.5 mg injection supplier
- Semaglutide weight management injection
- Wegovy 0.5 mg injection for weight management
- Wegovy FlexTouch pharmaceutical supplier
- Genuine Wegovy FlexTouch 0.5 mg
- Wegovy 0.5 mg international pharmaceutical supply
- Semaglutide injection exporter to USA
- Wegovy supplier to UK
- Wegovy exporter to Australia
- Wegovy supplier to Singapore
- Wegovy exporter to Canada
- Wegovy supplier to South Korea
- Wegovy exporter to UAE
- Pharmaceutical exporter from Nagpur India
- Prescription medicine exporter India
- GLP-1 receptor agonist supplier India
- Semaglutide pharmaceutical products India
Keywords







